Researchers in Taiwan have developed a new targeted therapy drug that preclinical trials suggest could inhibit the growth of tumors in nearly 30 percent of cancer patients.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Cross-Strait
Lai refutes PRC's claims over Taiwan in 1st of 10 speeches
06/22/2025 09:44 PM - Sports
Taiwan's men win bronze at Asian Fencing Championships in Bali
06/22/2025 09:14 PM - Society
CPC faces fine over Dalin refinery flare pollution
06/22/2025 08:38 PM - Society
Tropical depression off Iwo Jima could strengthen into typhoon: CWA
06/22/2025 08:31 PM - Culture
Taiwanese musicians wow Czech music festival
06/22/2025 08:22 PM